# The Study is to Investigate D-2570 in Participants With Different Levels of Kidney Function.

> **NCT07715175** · PHASE1 · NOT_YET_RECRUITING · sponsor: **InventisBio Co., Ltd** · enrollment: 40 (estimated)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** D-2570

## Key facts

- **NCT ID:** NCT07715175
- **Lead sponsor:** InventisBio Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-09
- **Primary completion:** 2026-11-21
- **Final completion:** 2026-11-21
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07715175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07715175, "The Study is to Investigate D-2570 in Participants With Different Levels of Kidney Function.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07715175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*